or
Bookmark and Share
   
Document Number
US Patent 5628985
Issued Date
May 13, 1997
Link
Inventors
Map
Abstract
A transparent liquid dentifrice which comprises a particulate silica abrasive material present in from 10 to 15% by weight of the composition, stably suspended in an aqueous liquid vehicle with the aid of a suspending agent; and a humectant system which consists essentially of sorbitol, present in from 50 to 55% by weight of the composition (measured as the 100% active), and polyethylene glycol with average molecular weight in the range 200 to 600, present in from 0.5 to 3% by weight of the composition.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
16
Comments:
no comments yet
Published
May 13, 1997
Application Number
08/452,201
Filed
May 26, 1995
US Classification
424/49   424/52
Int'l Classification
A61K   8/55   (20060101)   A61K   8/73   (20060101)   A61K   8/44   (20060101)   A61K   8/34   (20060101)   A61K   8/39   (20060101)   A61K   8/72   (20060101)   A61K   8/60   (20060101)   A61Q   11/00   (20060101)   A61K   8/30   (20060101)   A61K   8/19   (20060101)   A61K   8/25   (20060101)  
Examiner
Parent Case
This is a continuation of PCT application Ser. No. PCT/EP95/00557 filed Feb. 15, 1995 which claimed priority from GB 9403581.3 filed on Feb. 24, 1994, GB9410654.9 filed on May 27, 1994 and GB9424346.6 filed Dec. 2, 1994 .
Priority Data
Feb 24, 1994 [GB] 9403581 May 27, 1994 [GB] 9410654 Dec 02, 1994 [GB] 9424346
USPTO Field of Search
424/79   424/80   424/81   424/82   424/83   424/84   424/85   424/86   424/87   424/88  
Related Patents
5833956 - Oral composition containing an anionic, a nonionic and an amphoteric surfactant system - Owned by Colgate-Palmolive Company (New York, NY)

The invention provides a substantially nonirritating oral composition containing a surfactant system comprised of a combination of an anionic surfactant, an amphoteric surfactant and a nonesterified alkyl polyglucoside surfactant.

6479038 - Clear dentifrice gels - Owned by The Procter & Gamble Company (Cincinnati, OH)

According to the present invention there is provided a visually clear, dentrifice gel comprising; a) sufficient tetrasodium pyrophosphate to provide from 0.2% to 5% pyrophosphate anion; b) a silica dental abrasive having a refractive index of from 1.445 to 1.47; c) from 0.7% to 3% sodium alkyl sulphate; and d) an aqueous liquid carrier. The gel has excellent clarity, high anticalculus efficiency and good foaming. According to a further aspect of the invention there is provided a process for making a clear dentifrice gel comprising the step of adding anhydrous tetrasodium pyrophosphate to an aqueous carrier, the gel comprising: a) a silica dental abrasive having a refractive index of from 1.445 to 1.47; and b) an aqueous liquid carrier comprising less than 27% total water. The use of anhydrous tetrasodium pyrophosphate allows greater formulation flexibility at the processing stage by freeing up water for the dissolution and/or hydration of other dentrifice components.

6685919 - Plaque-controlling liquid tooth cleaning gel - Owned by Henkel Kommanditgesellschaft auf Aktien (Duesseldorf,DE)

A water based liquid tooth cleaning gel is presented with a viscosity below 50 Pa.multidot.s (20.degree. C.) comprising

6682719 - Plaque-controlling liquid tooth cleaning agent - Owned by Henkel Kommanditgesellschaft auf Aktien (Duesseldorf,DE)

There is provided a water-based liquid tooth cleaning gel with a viscosity below 50 Pa.multidot.s (20.degree. C.), comprising

6451291 - Surfactant system for increasing dental tissue antibacterial agent uptake - Owned by Colgate Palmolive Company (New York, NY)

An oral composition comprising in an orally acceptable vehicle, an effective antiplaque amount of an halogenated diphenyl ether or phenolic antibacterial compound, and an amount of an mixed anionic/zwitterionic surfactant system which is effective to increase the uptake of the antibacterial compound to dental tissue so as to enhance the therapeutic efficacy of the administered antibacterial compound.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us